Background: Adherence is necessary for efficacy of preexposure prophylaxis (PrEP), and text-messaging methods are promising tools for both adherence assessment and support. Although PrEP adherence is variable, little research has examined patterns of variability or factors associated with longitudinal use. Methods: In the context of a randomized controlled trial of text-messaging versus standard of care for PrEP adherence, 181 men who have sex with men receivedonce-daily tenofovir disoproxil fumarate/emtricitabine and daily adherence texts for 48 weeks. Growth mixture modeling (GMM) was used to identify subgroups of individuals with similar trajectories of text-reported adherence. Between-group differences in pharmacologic measures of adherence (ie, tenofovir diphosphate and emtricitabine triphosphate levels), as well as predictors and study-end attitudes associated with group membership, were examined. Results: GMM identified 4 trajectories of text-reported adherence. Classes with higher text-reported adherence had higher drug concentrations. Younger age and minority race were associated with lower adherence, and individuals in classes with lower adherence had greater baseline levels of depression, substance use concerns, and sexual risk. Differences in study satisfaction were also associated with adherence. Conclusions: This study supports the use of text-reported PrEP adherence. Identifying factors associated with less-than-optimal adherence may aid clinicians in anticipating at-risk patients requiring augmented intervention. Clinical trials registration: NCT01761643.
RCT Entities:
Background: Adherence is necessary for efficacy of preexposure prophylaxis (PrEP), and text-messaging methods are promising tools for both adherence assessment and support. Although PrEP adherence is variable, little research has examined patterns of variability or factors associated with longitudinal use. Methods: In the context of a randomized controlled trial of text-messaging versus standard of care for PrEP adherence, 181 men who have sex with men received once-daily tenofovir disoproxil fumarate/emtricitabine and daily adherence texts for 48 weeks. Growth mixture modeling (GMM) was used to identify subgroups of individuals with similar trajectories of text-reported adherence. Between-group differences in pharmacologic measures of adherence (ie, tenofovir diphosphate and emtricitabine triphosphate levels), as well as predictors and study-end attitudes associated with group membership, were examined. Results: GMM identified 4 trajectories of text-reported adherence. Classes with higher text-reported adherence had higher drug concentrations. Younger age and minority race were associated with lower adherence, and individuals in classes with lower adherence had greater baseline levels of depression, substance use concerns, and sexual risk. Differences in study satisfaction were also associated with adherence. Conclusions: This study supports the use of text-reported PrEP adherence. Identifying factors associated with less-than-optimal adherence may aid clinicians in anticipating at-risk patients requiring augmented intervention. Clinical trials registration: NCT01761643.
Authors: George Ayala; Trista Bingham; Junyeop Kim; Darrell P Wheeler; Gregorio A Millett Journal: Am J Public Health Date: 2012-03-08 Impact factor: 9.308
Authors: Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant Journal: Sci Transl Med Date: 2012-09-12 Impact factor: 17.956
Authors: Jose Castillo-Mancilla; Sharon Seifert; Kayla Campbell; Stacey Coleman; Kevin McAllister; Jia-Hua Zheng; Edward M Gardner; Albert Liu; David V Glidden; Robert Grant; Sybil Hosek; Craig M Wilson; Lane R Bushman; Samantha MaWhinney; Peter L Anderson Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan Journal: AIDS Behav Date: 2022-03-18
Authors: Maria Pyra; Russell Brewer; Laura Rusie; Jeanelle Kline; India Willis; John Schneider Journal: J Acquir Immune Defic Syndr Date: 2022-02-01 Impact factor: 3.771
Authors: Elizabeth C Pasipanodya; Michael J Li; Sonia Jain; Xiaoying Sun; Jessica Tobin; Eric Ellorin; Michael Dube; Eric S Daar; Katya Corado; Joel Milam; Jill Blumenthal; Sheldon H Morris; David J Moore Journal: AIDS Behav Date: 2020-11
Authors: Martin Hoenigl; Adiba Hassan; David J Moore; Peter L Anderson; Katya Corado; Michael P Dubé; Eric E Ellorin; Jill Blumenthal; Sheldon R Morris Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.771
Authors: Pamela Y Collins; Jennifer Velloza; Tessa Concepcion; Linda Oseso; Lydia Chwastiak; Christopher G Kemp; Jane Simoni; Bradley H Wagenaar Journal: J Int AIDS Soc Date: 2021-06 Impact factor: 5.396
Authors: Jennifer Velloza; Renee Heffron; K Rivet Amico; Ali Rowhani-Rahbar; James P Hughes; Maoji Li; Bonnie J Dye; Connie Celum; Linda-Gail Bekker; Robert M Grant Journal: AIDS Behav Date: 2020-07